✦ LIBER ✦

Carboplatin, ifosfamide, etoposide, and GM-CSF in advanced ovarian carcinoma, previously treated with cisplatinum

✍ Scribed by Botto, H.G.; Galvez, C; Palao Marco, F; Bonamasa, M.

Book ID: 122867858
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 141 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91366-S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined Carboplatin plus Ifosfamide and

Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I–II Study

✍ Vito Lorusso; Bernardo Leone; Giovanni Di Vagno; Luigi Manzione; Sergio Palmeri; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 71 KB

A phase II study of oxaliplatin, docetax

A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma

✍ Frederick Locke; Joseph I. Clark; Thomas F. Gajewski 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 268 KB

Comparison of 5 vs 10 μg/kg per day of G

Comparison of 5 vs 10 μg/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer

✍ C. Bokemeyer; H. -J. Schmoll; B. Metzner; J. Beyer; H. J. Illiger; M. Kneba; H. 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 545 KB

Treatment of advanced ovarian carcinoma

Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, andcis-platinum (HAC): Results in both untreated and previously treated patients

✍ Brower, Mark S. ;Coleman, Morton ;Pasmantier, Mark W. ;Silver, Richard T. ;Mamar 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Twenty-two patients with advanced (FIGO stages III and IV) adenocarcinoma of the ovary were treated with 28-day cycles of hexamethylmelamine, doxorubicin, and cis-dichlorodiamine-platinum (II) (HAC). After 45 months, there were 21 evaluable patients. The median survival was 16 months. Response was a

Prognostic significance of p53 mutation

Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin

✍ Yuko Ueno; Takayuki Enomoto; Yoshiro Otsuki; Nagatoshi Sugita; Ryuichi Nakashima 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 233 KB

A phase I/II study of a stepwise dose-es

A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours

✍ Bokemeyer, C.; Schmoll, H.-J.; Harstrick, A.; Illiger, H.J.; Metzner, B.; Räth, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 929 KB